Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-10
1995-01-10
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 77, C07D22102
Patent
active
053807286
ABSTRACT:
17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones of the formula: ##STR1## wherein the dotted line can represent a double bond when present,
REFERENCES:
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4845104 (1989-07-01), Carlin et al.
patent: 5324734 (1994-06-01), Gilbert
Stinson, Chem. & Eng. News, 29 Jun. 1992 pp. 7-8.
Daus Donald G.
Giesser Joanne M.
Matukaitis Paul D.
Merck & Co. , Inc.
Winokur Melvin
LandOfFree
Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850762